What is the value of the global Sepsis Diagnostics Market?

In 2022, the global Sepsis Diagnostics Market was valued at USD 628.7 million.

What will be the market size for Sepsis Diagnostics Market in 2032?

In 2032, the Sepsis Diagnostics Market will reach USD 1392.8 million.

What CAGR is projected for the Sepsis Diagnostics Market?

The Sepsis Diagnostics Market is expected to grow at 8.5% CAGR (2023-2032).

List the segments encompassed in this report on the Sepsis Diagnostics Market?

Market.US has segmented the Sepsis Diagnostics Market Market by geographic (North America, Europe, APAC, South America, and MEA). By Product Type, market has been segmented into Blood Culture Media, Instruments, Assay Kits and Reagents and Other Product Types. By Pathogen, the market has been further divided into Bacterial Sepsis, Fungal Sepsis, Viral Sepsis and Other Pathogens.

Which segment dominate the Sepsis Diagnostics industry?

With respect to the Sepsis Diagnostics industry, vendors can expect to leverage greater prospective business opportunities through the Blood Culture Media segment, as this dominate this industry.

Name the major industry players in the Sepsis Diagnostics Market.

Becton, Dickinson, and Company, Abbott Laboratories Inc, F. Hoffmann-La Roche AG, BioMérieux SA, Thermo Fisher Scientific Inc and Other Key Players are the main vendors in this market.

Global Sepsis Diagnostics Market By Product Type (Blood Culture Media, Instruments, Assay Kits and Reagents, and Other Product Types), By Pathogen (Bacterial Sepsis, Fungal Sepsis, Viral Sepsis), By Diagnostic Method, Technology, By End-user, By Region and Companies - Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032

Published date: Aug 2024
Report ID: 103467
Number of Pages: 325
Format:

Overview
Table of Contents
Major Market Players
Request a Free Sample

- Becton, Dickinson, and Company
- Abbott Laboratories Inc.
- F. Hoffmann-La Roche AG
- BioMérieux SA
- Thermo Fisher Scientific, Inc.
- Danaher Corporation
- T2 Biosystems Inc.
- Luminex Corp.
- Immunexpress, Inc.
- Bruker Corporation
- Axis-Shield Diagnostics Ltd
- Other Key Players